Shuttle Pharmaceuticals Holdings, Inc.
NASDAQ: SHPH0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- NASDAQ Global Market
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- CEO
- Christopher Robert Cooper
- Employees
- 9
- Headquarters
- Gaithersburg, United States
- IPO year
- 2022
- Market cap
- $2.2M
- Website
- https://www.shuttlepharma.com
Loading SHPH…
Loading profile data…Frequently asked questions about SHPH
What does Shuttle Pharmaceuticals Holdings, Inc. (SHPH) do?
Shuttle Pharmaceuticals Holdings, Inc., in conjunction with its subsidiary Shuttle Pharmaceuticals, Inc., is committed to the identification, advancement, and commercialization of pharmaceutical agents crafted to heighten the susceptibility of cancerous cells to radiation therapy. Its current portfolio of clinical-phase treatments features Ropid...
Where does SHPH trade?
Shuttle Pharmaceuticals Holdings, Inc. (SHPH) trades on the NASDAQ Global Market.
What sector is SHPH in?
Shuttle Pharmaceuticals Holdings, Inc. (SHPH) operates in the Healthcare sector, specifically in the Drug Manufacturers - Specialty & Generic industry.
Who is the CEO of Shuttle Pharmaceuticals Holdings, Inc.?
Christopher Robert Cooper is the chief executive officer of Shuttle Pharmaceuticals Holdings, Inc. (SHPH).
Where is Shuttle Pharmaceuticals Holdings, Inc. headquartered?
Shuttle Pharmaceuticals Holdings, Inc. is headquartered in United States.
Does SHPH pay a dividend?
Shuttle Pharmaceuticals Holdings, Inc. (SHPH) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did SHPH go public?
Shuttle Pharmaceuticals Holdings, Inc. (SHPH) completed its initial public offering in 2022.